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Abstract
Background: The vitamin B12 and folate status in nonanaemic healthy older persons needs attention the more so
as decrease in levels may be anticipated from reduced haematinic provision and/or impaired intestinal uptake.
Methods: A total of 1143 subjectively healthy Swiss midlands participants (637 females and 506 males), ≥60 years
of age were included in this study. Levels of vitamin B12, holotranscobalamin (holoTC), methylmalonic acid (MMA),
homocysteine (Hcy), serum folate, red blood cell (RBC) folate were measured. Further, Fedosov’s wellness score was
determined. Associations of age, gender, and cystatin C/creatinine-based estimated kidney function, with the
investigated parameters were assessed. Reference intervals were calculated. Further, ROC analysis was done to
assess accuracy of the individual parameters in recognizing a deficient vitamin B12 status. Finally, decision limits
for sensitive, specific and optimal recognition of vitamin B12 status with individual parameters were derived.
Results: Three age groups: 60–69, 70–79 and≥ 80 had median B12 (pmol/L) levels of 237, 228 and 231 respectively
(p = 0.22), holoTC (pmol/L) of 52, 546 and 52 (p = 0.60) but Hcy (μmol/L) 12, 15 and 16 (p < 0.001), MMA (nmol/L) 207,
221 and 244 (p < 0.001). Hcy and MMA (both p < 0.001), but not holoTC (p = 0.12) and vitamin B12 (p = 0.44) were
found to be affected by kidney function. In a linear regression model Fedosov’s wellness score was independently
associated with kidney function (p < 0.001) but not with age. Total serum folate and red blood cell (RBC) folate drift
apart with increasing age: whereas the former decreases (p = 0.01) RBC folate remains in the same bandwidth across all
age groups (p = 0.12) A common reference interval combining age and gender strata can be obtained for vitamin B12
and holoTC, whereas a more differentiated approach seems warranted for serum folate and RBC folate.
Conclusion: Whereas the vitamin B12 and holoTC levels remain steady after 60 years of age, we observed a significant
increment in MMA levels accompanied by increments in Hcy; this is better explained by age-related reduced kidney
function than by vitamin B12 insufficiency. Total serum folate levels but not RBC folate levels decreased with
progressing age.
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Background
The clinical significance of water soluble vitamin B12
(cobalamin) and of folate, and the importance of their
routine analysis, is supported by recent findings in
physiology regarding their function [1–8]. The simple
yet biologically important role of support by these vita-
mins in catalysis of methyl group transfer is essential for
life maintenance [9]. The function of folate overlaps with
vitamin B12 both of them being essential in methylation
reactions. With telomere shortening emerging as a re-
search topic of senescence, it has been shown that the
one-carbon metabolism pathway may affect telomere
length through DNA-methylation [10].
Vitamin B12 deficiency later in life is estimated to affect
10 % of people over the age of 60 [11, 12]. Recent metaana-
lytic surveys [13, 14] confirmed the finding of vitamin B12-,
and folate- deficiencies in elderly patients [15]. Optional
but frequently practiced fortification of grain-based food
supply is done with folic acid and vitamin B12
(www.blv.admin.ch).
Next to vitamin B12, folates are essential in eukaryotic
cells for single carbon transfer reactions. Folate receptors
transport their ligand via endocytosis [16] and jejunal folate
resorption is of no clinical concern unless viral infection in-
terferes [17]. In contrast the vitamin B12/gastric intrinsic
factor cargo undergoes a risky trip down to ileal uptake in-
volving vitamin B12 detachment from food proteins, and
pancreatic protease scission of the vitamin B12-haptocorrin
complex. There has recently been an upsurge of interest in
the proper functioning of these interactions because of the
extension of life expectancy and a concomitant increase in
comorbidity, requiring updates in medical-geriatric check-
ups [18]; early diagnosis in the elderly of vitamin deficiency
is mandatory [19]. Some sources propose RBC folate a
more stable indicator of folate sufficiency because of its
intracellular confinement.
It is not enough to quantitatively estimate total vita-
min B12 in order to test for vitamin B12 deficiency. It is
true that MMA and Hcy are surrogate markers for vita-
min B12 deficiency, and correctly indicate vitamin B12
failure to produce succinic acid and methionine. How-
ever, the effectiveness of these markers also depends on
kidney function, which is now assessed by measuring the
age-related impairment of glomerular filtration rate
(eGFR: estimated equations) [20, 21]. In fact, kidney
clearance of both MMA and Hcy is compromised in re-
duced kidney function [21].
Reference intervals (RI) for most laboratory analysis
are now included by the providers of automatic instru-
ment systems; their establishment is part of the brand
and often calculated with serum banks of healthy blood
donors in their work force age groups. In addition sex
differences are issued only for relating analytes, mostly
endocrinological.
It remains the responsibility of a laboratory to trans-
late the RIs into good medical practice. RIs established
with healthy sample donors from the region served by
the medical laboratory need to be compared to those
provided by the manufacturer of automated platforms
and adjustments [22–24] made as required. The Swiss
SENIORLAB study (www.seniorlabor.ch) is a study with
over 1400 elderly participants allowing establishment of
reference intervals of different analytes including vitamin
D [25] and, analyzed here, vitamin B12/folate status.
Methods
Study population
Subjects were recruited from February 2009 to December
2011 in the context of the Swiss SENIORLAB study,
which is an ongoing investigation in the canton of
Berne (Switzerland) aimed at creating appropriate
reference intervals (RI’s) of several analytes in the se-
nior citizens (http://www.seniorlabor.ch). Subjectively
healthy senior Caucasian volunteers aged 60 years and
older were recruited. The study participants were con-
tacted through newspaper advertisements, clubs and
associations where there was a high probability that the
membership would include healthy senior citizens
(e.g., mountaineering clubs, sports clubs) and through
personal contacts of those involved in organizing the
study. A personal history of the patients was taken
including specific information on medication and
presence of several common diseases such as known
cardiovascular disease, known diabetes mellitus,
known thyroid disease, or known cognitive impairment.
Anthropometric measurements were performed, and ven-
ous blood was drawn into S-Monovettes® (Sarstedt, Sevelen,
Switzerland) after an overnight fasting period. In a longitu-
dinal follow-up after baseline examination, all study partici-
pants were contacted and questioned on several issues
regarding quality of life and survival. In the determination
of reference intervals in elderly persons, survival can be
employed to demonstrate a certain degree of health [26].
Of the 1467 participants, those with high C-reactive
protein levels (>10 mg/L), vitamin B12-outliers (vitamin
B12 > 1100 pmol/L), holoTC-outliers (holoTC >128
pmol/L), serum folic acid outliers (>45.3 nmol/L) or a
hemoglobin suggesting anemia in the elderly (<110 g/L)
[27] were excluded. Further exclusion criteria comprised
the intake of proton pump inhibitors, antidiabetic medi-
cation, and vitamin B12 or folic acid supplementation as
well as a clinical history suggesting the presence of cog-
nitive impairment or a survival of less than one year
(Fig. 1). Of the included study participants, 515 were be-
tween 60 and 69 years old, 435 between 70 and 79 years
and 193 were 80 years old or older (Table 1). This study
was in accordance with the Declaration of Helsinki and
was approved by the cantonal institutional review board
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(KEK-Bern 166/08). All of the participants provided
written informed consent.
Biochemical measurements
Analyses were performed on whole blood anticoagulated
with EDTA, separated plasma therefrom or serum and kept
at room temperature, on the same day of morning blood
drawing. For CBC we use a Sysmex XE-5000 automated
hematology analyzer (Sysmex, Horgen, Switzerland) provid-
ing 38 haematology values.
Total vitamin B12 and serum folic acid were assayed
using the Abbott Architect i2000 analyzer (Abbott
Diagnostics, Baar, Switzerland). Holotranscobalamin
(holoTC) was assayed using an Axsym platform (Abbott
Diagnostics, Baar, Switzerland). Because of restricted funds,
only a partial sample (n = 1063) was analyzed on a
SCIEX API 4000 LC-MS/MS system (AB Sciex, Brugg,
Switzerland) for methyl malonic acid (MMA) [22, 28–32].
RBC folic acid was estimated using the relationship be-
tween red blood cell folate level, as measured with
Beckman Unicel DxI 800 (Beckman Coulter, Nyon,
Switzerland) and hematocrit. Creatinine was tested
using an IDMS-standardized kinetic Jaffe method
(Roche Diagnostics, Rotkreuz, Switzerland). The cystatin
C levels and high sensitive CRP were determined using
the nephelometric method with a Siemens Prospec
Fig. 1 Chart representing all the recruited participants with those retained and those excluded from the study (n = number of participants).
*Some participants fulfill several exclusion criteria
Table 1 Baseline characteristics. The parameters given are associated with markers of vitamin B12 and folic acid status and are
classified according to three different age groups. P-values are given for differences among the three different groups
60-69 yrs 70-79 yrs ≥80 yrs P values+
Female/Male (n) 278/237 247/188 112/81 0.53
Hb (g/L) 143.00 (136.00, 151.00); n = 515 142 (134, 149.00); n = 435 139 (131.00, 146.00); n = 193 <0.001
MCV (fl) 89.00 (87.00, 91.00); n = 515 90.00 (87.00, 92.00); n = 435 91.00 (88.00, 93.00); n = 193 <0.001
Fedosov’s ω 0.13 (−0.13, 0.36); n = 463 0.02 (−0.30, 0.33); n = 411 −0.10 (−0.39, 0.22); n = 184 <0.001
B12 (pmol/L) 237 (190, 292); n = 515 228 (180.00, 292); n = 435 231 (185, 301); n = 193 0.22
holoTc (pmol/L) 52.3 (41.0, 66.0); n = 508 54.1 (39.3, 69.0); n = 432 51.8 (38.2, 67.3); n = 193 0.60
MMA (nmol/L) 207 (169, 261.00); n = 467 221 (179, 294); n = 412 244 (190, 326); n = 184 <0.001
Hcy (μmol/L) 12.5 (10.5, 14.80); n = 515 13.9 (11.6, 16.7); n = 435 15.5 (12.8, 19.9); n = 193 <0.001
Serum folate (nmol/L) 19.5 (13.8, 27.0); n = 515 17.7 (12.9; 25.3); n = 4354 17.2 (13.0, 25.3); n = 193 0.01
Red cell folate (nmol/L) 899 (700,1157); n = 498 870 (669,1157); n = 431 837 (646, 1136); n = 192 0.17
Folate/B12 83.4 (58.9, 116.3); n = 515 81.5 (55.9, 112.0); n = 435 76.8 (57.3, 104.5); n = 139 0.09
eGFR (ml/min/1.73 m2) 90 (82, 98); n = 515 82 (69, 89); n = 435 67 (54, 78); n = 193 <0.001
Mentzer index 18.70 (17.60, 19.79); n = 515 18.94 (17.77, 20.22); n = 435 20.0 (18.33, 21.09); n = 193 <0.001
Footnote: Values are median and interquartile range (IQR) for continuous variables. n = number
+Kruskal-Wallis test for continuous variables; chi square test for proportion female/male
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instrument (Siemens Zurich, Switzerland). The α-amino
acid homocysteine (Hcy) was measured using chemilu-
minescence on a Immulite 2000 instrument (Siemens,
Zurich, Switzerland). The coefficient of variation in meas-
uring the parameters of vitamin B12 and folic acid metab-
olism in our hands was 6.6 % for vitamin B12 (at a mean
concentration of 162 pmol/L) 8.7 % for folic acid in serum
(18.9 nmol/L), 6.8 % for holoTC (46 pmol/L), 9.3 % for
Hcy (12.9 μmol/L), and for 1.8 % for MMA (390 nmol/L).
Estimated glomerular filtration rate (eGFR) was computed
using the combined CKD-EPI version involving creatinine
and corrected cystatin C level (Chronic Kidney Disease
Epidemiology Collaboration) [20, 33, 34]. The Mentzer index
was calculated by dividing the RBC count into the MCV [35].
The Fedosovwellness quotient (ω; combined indicator of vita-
min B12 status) was calculated according the formula: ω=
log10(holoTCn) + log10(B12n) - log10(MMAn) - log10(Hcyn),
where variables correspond to the combination of the vari-
ables into normalized concentrations; for example, holoTCn
= holoTC/holoTcnormal [36, 37]. The normal concentrations
were obtained from reference [36]. Accuracy and precision of
our assays comply with external and internal quality control
requirements of the Swiss commission for quality assurance
in themedical laboratory (QUALAB).
Data analysis
We used descriptive statistical methods to define reference
intervals and to cross-compare blood concentrations of dif-
ferent analyte values. To find a non-parametric association
between selected analyte concentrations we sought for sig-
nificance of Spearman rank order correlation. Reference in-
tervals for total B12, holoTC, folate and RBC folate were
calculated by means of the non-parametric method, as rec-
ommended by the CLSI guideline C28-A3c [38, 39]. The
prevalence of vitamin B12 deficiency was assessed by Fedo-
sov’s quotient [36]. The Kruskal-Wallis test was employed
to evaluate differences in analyte concentrations among dif-
ferent age-groups (60–69, 70–79 and ≥80). Proportions
were compared by chi-square test and chi-square test for
trend. To characterize the diagnostic accuracy of the differ-
ent analytes, receiver operating characteristic (ROC) curve
analysis was performed; cutoff thresholds and ROC analysis
of 4 separate markers of vitamin B12 deficiency (vitamin
B12, holoTC, MMA, Hcy) was calculated assuming nega-
tive values ω < − 0,5 point to vitamin B12 deficiency [36].
Analogously to Fedosov [35], we used ROC curve analysis
to determine the optimum decision threshold for the indi-
vidual markers as lower cut-off for evaluation of a vitamin
deficiency. We also determined the cut-offs, where an indi-
vidual marker possesses a sensitivity or specificity of at least
99 %. As a marker of diagnostic accuracy, the areas under
the curve of individual markers were compared according
to DeLong et al. [40] Linear regression analysis was also
done, in order to investigate a relationship between the
metabolites Hcy and MMA with kidney function, inde-
pendent of vitamin concentrations. The computer program
Medcalc version 14.12.0 (Mariakerke, Belgium) was
used for statistical calculations. Graphs were con-
structed by Medcalc and Graphpad Prism version 5.04
(GraphPad Software, La Jolla, USA).
Results
Vitamin B12 and surrogate markers
Spearman rank correlations revealed statistically insignifi-
cant associations between vitamin B12 or holoTC and pro-
gressing years of age (p = 0.56 and p = 0.68). Total vitamin
B12 serum levels and holoTC in the entire cohort thus
remained stable over three arbitrarily defined age groups of
60–69, 70–79 and ≥80 year (Table 1). However, there were
significant sex differences of holoTC in the age groups of
60–69 (p < 0.001), 70–79 years (p < 0.001), whereas no such
differences could be detected in persons ≥ 80 years
(p = 0.77) (Fig. 2 and Fig. 3). Therefore, a common ref-
erence interval for elderly persons could be determined for
persons aged ≥80 year (21.3 (90 % confidence interval, CI,
19.3-24.0) – 118.2 (90 % CI 97–125.3) pmol/L), whereas
Fig. 2 Vitamin B12 and holoTC serum levels in three arbitrarily
defined advanced age groups classified according to sex. The box
plot representation with vitamin B12 (panel a) and holoTC (panel
b) as appearing in three age groups. The difference of vitamin B12
concentrations among males and females is significant in 70–79
year old (p = 0.001) and not significant in the participants aged
60–69 (p = 0.07) and ≥ 80 years (p = 0.69). The same comparisons
of holoTC concentrations are significant for participants aged
60–69 and 70–79 (both p < 0.001), and not significant in the
particpants ≥ 80 years (p = 0.77)
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sex-specific reference intervals can be given for persons
from 60–79 years: 24.0 (90 % CI 21.0 – 25.6) – 115 (90 %
CI 107.9 – 119.0) pmol/L in females and 22.3 (90 % CI
and 21.0–24.5) – 94.4 (90 % CI 85.4–106.2) pmol/L for
males. Because the 90 % CI’s overlap in both age groups
and among both sexes, a combined lower limit of the ref-
erence interval might be justifiable and useful practical
purposes. Because the upper limit of the reference interval
is of minor clinical importance and the differences among
age and sex groups can be regarded as small, the same
practical considerations can be extraopolated to the com-
mon upper limit of the reference interval. A combined ref-
erence interval for both sexes and persons ≥ 60 years can
thus be determined at 23 (90 % CI 21.9–24) – 109.3 (90 %
CI 105 – 115) pmol/L.
When looking at sex differences of vitamin B12 concen-
trations in the 3 different age groups, significant differ-
ences between female and male participants can only be
seen in the age group of 70–79 years (p < 0.001) (Fig. 2).
Combined reference intervals for the age groups of 60–
69 years and ≥ 80 year are: 124 (90 % CI 115–134) – 470
(90 % CI 428 – 507) pmol/L. The sex-specific reference in-
tervals for the age group of 70–79 years are: 106 (90 % CI
77–122) – 443 (90 % CI 349–672) pmol/L for men and
113 (90 % CI 101–126) – 490 (90 % CI 442–511) pmol/L
for females. As found above with holoTC the confidence
intervals of the upper and lower limits overlap between
the different groups. A single reference interval combining
all age and sex groups for practical purposes thus also
seems justifiable. A common reference interval for vitamin
B12 in elderly persons thus can be determined at 119
(90 % CI 114–126) – 465 (90 % CI 442–497) pmol/L.
The prevalence of metabolic vitamin B12 deficiency
[Fedosov’s wellness quotient ω < −0.5] in our cross-sec-
tional survey, within the three age groups 60–69,
70–79 and ≥80 year were significantly different and
showed a significant trend (p < 0.001 for both) as follows:
8.0 % (37/426), 13.4 % (55/356) and 19.0 % (35/149).
There was a statistically significant increase in
serum concentrations of Hcy and MMA with advan-
cing age (p < 0.001 for both analytes); because it is
known that these analytes pass the glomerular barrier,
their senescent increment depends on eGFR, which
significantly deteriorated over the three age groups
(p < 0.001) (Table 1). Additional file shows this in more de-
tail [Additional file 1]. Using a linear regression model
employing age, serum folate, vitamin B12, gender and eGFR
as independent and Hcy or MMA as dependent variables
revealed a highly significant (p < 0.001) inverse relationship
of both Hcy and MMA with eGFR. It should be noted that
both vitamin B12 (p = 0.44) and holoTC (p = 0.12) were un-
related to eGFR in univariate analysis but also in a regres-
sion model adjusting for age and gender [Additional file 2].
The Fedosov wellness quotient calculated from the
four vitamin B12 dependent analytes exhibited a statisti-
cally weak inverse correlation with progressing age in
univariate analysis (r = −0.153, p < 0.001) [41]. However,
a linear regression model (R2 = 0.95) incorporating MMA,
Hcy, holoTc, vitamin B12, eGFR and gender as independ-
ent and Fedosov’s wellness quotient as dependent variable
reveals the four parameters of vitamin B12 status as well
as kidney function to be independent predictors (p < 0.001
for all) of Fedosov’s wellness score. Age (p = 0.97) and
gender (p = 0.59) did not have a significant association in
this model.
To scrutinize the diagnostic accuracy of vitamin B12
dependent analyses, we performed a ROC analysis (Fig. 2).
It appears that the largest area under the curve (AUC) is
seen with holoTC: 0.923 (95 % CI 0.905-938), followed by
MMA: 0.916 (95 % CI 0.897-0.932), followed by vitamin
B12: 0.884 (95 % CI 0.863-0.903); Hcy reached an AUC
value of 0.807 (95 % CI 0.782-0.831). A comparison of the
AUC revealed holoTC to display significantly better diag-
nostic characterstics than vitamin B12 (p = 0.03) and homo-
cysteine (p < 0.001). HoloTc (p < 0.001), MMA (p < 0.001)
and vitamin B12 (p = 0.009) had significantly better diag-
nostic characteristics than Hcy. There were no differences
in AUC between holoTC and MMA (p = 0.67) as well as
between MMA and vitamin B12 (p = 0.14). As obtained by
ROC curve analysis, the three decisive cut-offs (cut-off with
99 % specificity, cut-off with 99 % sensitivity, optimum de-
cision threshold) for the different markers were: >25.8 pmol
(specificity 99.04 %; sensitivity 32.81 %), ≤57 pmol/L (sensi-
tivity 99.22 %; specificity 46.06 %), ≤43.2 pmol/L (sensitivity
93.75 %; specificity 75.85 %) for holoTC; >485 nmol/L (spe-
cificity 99.04 %; sensitivity 32.81 %), ≥216 nmol/L (sensitiv-
ity 99.22 %; specificity 55.85 %), ≥284 nmol/L (sensitivity
85.94 %; specificity 82.55 %) for MMA; ≤131 pmol (specifi-
city 99.04 %; sensitivity 29.69 %), ≤316 pmol/L (sensitivity
99.22 %; specificity 20.21 %), ≤194 pmol/L (sensitivity
Fig. 3 Receiver operating characteristic (ROC) curves of vitamin B12,
holoTC, MMA and Hcy. The Fedosov wellness parameter ω = −0.5
was used as a separator of the groups assumed deficient and
assumed healthy
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83.59 %; specificity 77.55 %) for vitamin B12; >9,5 μmol/L
(specificity 11.17 %; sensitivity 99.22 %), ≥26.8 μmol/L (sen-
sitivity 9.38 %; specificity 99.04 %), ≥15.1 μmol/L (sensitivity
77.34 %; specificity 72.87 %) for Hcy. As an alternative to
reference intervals, a 2 cut-off model indicating probable
vitamin B12 deficiency, probable sufficient vitamin B12 sta-
tus as well as a greyzone can be derived from these cut-offs.
For the 4 investigated parameters, these cut-offs are given
in a separate table (Table 2).
Together, the specific cut-offs of holoTC (25.8 pmol/L)
and vitamin B12 (131 pmol/L) as determined by bio-
chemical vitamin B12 status obtained by Fedosov’s well-
ness quotient and ROC curve analysis fall close to the
90 % CI of the lower limit of the combined reference
interval for holoTC (21.9-24.0 pmol/L) and vitamin B12
(114-126pmol/L).
Folate
The total serum folate decreased with increasing age
(r = − 0.08; p = 0.01). Further, significant sex-specific
differences can be seen in the age groups from 60–79
(p < 0.001) but not in individuals ≥80 years (p = 0.07).
The sex-specific reference intervals in the age group
60–69 years are: 8.1 (90 % CI 6.3-8.8) – 40.8 (90 % CI 36.8-
45.1) nmol/L for males and 9.6 (90 % CI 8.4-10.7) – 43.3
(90 % CI 42.3-44.6) nmol/L for females. In the age group
70–79 years, the sex-specific reference intervals are 6.7
(90 % CI 3.7-8.1) – 37.1 (90 % CI 34.5- 44.1) nmol/L in
males and 9.1 (90 % CI 7.4-9.8) – 43.9 (90 % CI 40.4- 45.1)
nmol/L in females. A combined reference interval for the
age group ≥ 80 years can be determined at 8.0 (90 % CI
6.5 – 8.7) – 43.0 (90 % CI 39.2-45.1) nmol/L. A reference
interval combining all gender and age strata for practical
purposes reveals a lower limit of 8.2 (90 % CI 7.6-8.5) and
an upper limit of 42.8 (90 % CI 41.4-43.8) nmol/L.
Interestingly, RBC folate remained stable over increasing
age (r =− 0.045, p = 0.12), There was a significant difference
in RBC folate levels in females and males (p = 0.02). Ac-
cordingly, gender specific reference intervals for all age
groups were calculated. The reference interval was 452
(90 % CI 396–503) – 1885 (90 % CI 1735–2045) nmol/L
for males and 435 (90 % CI 399–485) – 2067 (1903–2331)
nmol/L for females. Finally, a reference interval combining
all gender and age strata for practical purposes reveals a
lower limit of 444 (90 % CI 408–480) and an upper limit of
1934 (90 % CI 1869–2066) nmol/L.
As age increased, the folate/vitamin B12 ratio tended
to decrease (r = 0.06, p = 0.049), an observation in line
with the observation that serum levels of folic acid re-
cede with age by contrast with vitamin B12. Serum folate
and Hcy were inversely correlated (r = − 0.485, <0.001).
As a matter of fact, such correlation was better than the
one resulting from comparison of vitamin B12 and Hcy
(rs = −0.253, p < 0.001). There was a significant correl-
ation of serum folate with eGFR (r = 0.10; p < 0.001)
[Additional file 2]. Such an association was absent with
RBC folate (r = 0.01; p = 0.58) [Additional file 2]. In a lin-
ear regression model incorporating age, sex and eGFR as
independent and serum folate as dependent variable
maintained the independent relationship of eGFR and
serum folate (p = 0.03).
Discussion
Our study on subjectively healthy elderly Caucasian par-
ticipants from a circumscribed geographical region
shows for the first time that holoTC, but also vitamin
B12 levels from 60 year onwards remain within RIs set
by international expert panels with people from all ages
[42, 43] whereas serum folate concentrations – though
not RBC folate - recede to some extent. It could be
shown that MMA, Hcy as well as Fedosov’s wellness
quotient rather are associated with kidney function than
with age. Finally, we were able to present reference in-
tervals and decision limits for the different investigated
markers in the elderly.
An overwhelming proportion of the literature implies
that, with progressing age, vitamin B12 and folate levels
in senior citizens fall short of currently validated RIs
[44–48], a finding that is challenged by our data, ob-
tained from participants apparently in good health and
with a relatively uniracial background [49, 50]. Most
other studies, on metaanalysis, reveal cohorts com-
prised of study subjects seeking treatment or already ill
or even subject to multimorbidity [14, 47, 51, 52]. The
recruitment of study subjects apparently devoid of cog-
nitive impairment might further augment the propor-
tion of those with maintained vitamin B12 and folate
levels now known to impinge on cognitious perform-
ance ([44, 45, 53–55]. With the recent discoveries re-
garding the indispensable functions of vitamin B12 and
folate in living organisms [1, 2, 7], it comes as little sur-
prise that vitamin B12 and, to a lesser extent, folate,
maintain their levels throughout our life cycle or else
the participating subjects would not have been able to
Table 2 Cut-offs indicating probable vitamin B12 deficiency,
probable vitamin B12 sufficiency and a grey zone of diagnostic
uncertainty. These cut-offs are given for four markers of vitamin
B12 status and were obtained by ROC-analysis
Probable vitamin
B12 deficiency
Grey zone Probable vitamin
B12 sufficiency
Vitamin B12 (pmol/L) <131 131 – 315 ≥316
Holotranscobalamin
(pmol/L)
<25.8 25.8 – 56.9 ≥57.0
MMA (nmol/L) >485 217 – 485 ≤216
Homocysteine
(μmol/L)
>26.8 9.6 – 26.8 ≤9.5
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enter the study in advanced age under the classification
‘healthy’.
This was a community-dwelling cohort and haematinic
sufficiency [56] can be assumed among participants whose
BMI was normal and who were omnivorous, well fed and
unlikely to be vegetarians. Marginal vitamin B12 haematinic
provision remains a topic in daily health care. Switzerland
counts only around 20.000 lactovegetarians distributed over
all age groups: inadequate dietary intake of these two vita-
mins cannot be regarded as a relevant issue in this study.
The effect of food fortifications on the levels of vitamin B12
and folate could not be addressed. With the Canadian
Health Measures Survey on healthy folate replete subjects,
the prevalence of folate deficiency was close to zero while
vitamin B12 deficiency (cutoff < 148 pmol/L) came up to
5 % [43] but without effect of advanced age in older adults
(60–79 years). In Switzerland, intentional fortification of
food with vitamin B12 and folic acid is not enforced by law
unless vitamin supplementation is a recommended compo-
nent of pregnancy care. We thus might assume that dietary
intake by the healthy elderly studied here is adequate.
The drop in folate but not RBC folate levels observed
here may be linked to an intracellular maintenance of
folic acid entrapped in RBCs but no full explanation can
be forthcoming until half-life studies in both body com-
partments, plasma and RBC, have been conducted. Some
authors hold that free and RBC folate are equivalent [57]
and guidelines from the UK judge serum folate measure-
ment as sufficient for clinical purpose [58]. Some are of
the opinion that estimation of RBC folate is required to
appreciate general tissue folate supply; should the latter
view prevail for interpretation of our observations, then
increasing age at least is not connected to folate
deficiency.
In line with acknowledged understanding, our study links
the surrogate markers of vitamin B12 status, i.e., MMA &
Hcy, more closely to waning kidney function than to age. It
is widely confirmed that with advancing age and particu-
larly over age 50, functional kidney performance declines
by > 1 ml/min/year/1.73 m2 eGFR [59–61]. Our cohort
confirms receding kidney function with progressing
age ≥60 years using state-of-the art evaluation with
creatinine and corrected cystatin C levels [20]. Thus
logic would dictate that there are limits to applicability
of MMA and Hcy as surrogate markers in geriatrics.
Unhelpfully, quite a few studies have used claims of
high levels of MMA and Hcy to underscore their find-
ings of vitamin B12/folate reductions without testing
for impaired kidney function, which is now well ac-
knowledged, to increase MMA and Hcy levels [62].
It is noteworthy that significantly lower, but still nor-
mal, vitamin B12 median levels emerge in elderly males
by comparison with females in the 60–79 years age
range. Although no such sex difference showed up in a
Canadian-HMS cycle 1 [43], it was observed that elderly
males clearly were at higher risk for Vitamin B12/folate
deficiency in a NHANES survey on 1770 elderly persons
[47] and in our study women maintain sufficient vitamin
B12/folate levels from their reproductive life cycle
onwards.
In our study we have seen an increment in MCV with
increasing age. Although the index values steadily in-
crease by merely 1 fl from the youngest to the oldest age
group, the difference is statistically significant because of
the narrow distribution. This observation confirms pre-
vious reports indicating a link between macrocytosis and
poorer age-related cognitive performance [18]; the selec-
tion criteria prior to study entry used here preclude such
an association in the cohort studied here [52]. Out of
curiosity, we also estimated the Mentzer index, now
undergoing a revival as a test for safety of stem cell
apheresis from healthy donors [35]. The values here ob-
tained confirm those observed with MCV and in our
case served as a validity criterion for our observations.
In an earlier report on a small subsample of the
present cohort, we reported a borderline difference of
eGFR in participants with low and normal holoTC [38].
In line with other investigations, we now could demon-
strate that holoTC is not influenced by kidney function
[63]. The fact that we found holoTC to possess the high-
est accuracy in recognizing an insufficient vitamin B12
status together with the independence of the parameter
from reduced kidney function (a problem often occur-
ring in the elderly) and from age seems to make holoTC
an attractive first line choice for assessing vitamin B12
status in the elderly.
There are several possibilities to interpret markers of
vitamin B12 and folate status. The most often used ap-
proach is the comparison with reference intervals. We
were able to report reference intervals for all relevant
parameters relating to the investigation of vitamin B12
and folate status in the elderly. Each of the reported
stratum provides results from far more than 120 sub-
jects, a lower limit generally accepted for evaluation of
valid reference intervals [39]. Reference intervals have
been reported from substantially smaller collectives [22].
The present investigation to the best of our knowledge
is the largest collective of elderly persons, where refer-
ence intervals for vitamin B12 and folate status have
been derived in an integral approach.
Another way of interpreting laboratory results is the
comparison with pathophysiological conditions. We also
have taken this approach with ROC curve analysis, which
allows to describe areas of relative certainty (i.e., above or
below two cut-offs) together with a greyzone. Interestingly,
the lower limits of the reference intervals are similar to the
specific but insensitive cut-offs. Applying classically evalu-
ated reference intervals for assessment of vitamin B12
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deficiency can thus be regarded as very specific and rela-
tively insensitive. Within the difficult context of diagnosing
vitamin B12 and folate deficiency, we think that using an
approach with decision limits provided in Table 2 is prefer-
able to the use of reference intervals. Unfortunately, a func-
tional score for detecting folate deficiency in analogy to the
Fedosov wellness quotient in vitamin B12 deficiency is lack-
ing so far.
Our study contains limitations:
(i) The medication and supplementation intake of the
participants was self-reported. It might be that some
patients had supplements and medications leading to
erroneous inclusion of a participant in this analysis.
We can therefore not rule out the possibility that a
portion of our participants have normal vitamin B12
levels because supplemented. As impaired cognition
was an exclusion criterion, it can be assumed that
the number of affected individuals is low.
(ii)It is unfortunate that the questionnaire for study
subjects did not include more details on eating
habits
Conclusions
Whereas the vitamin B12 and holoTC levels remain
steady after 60 years of age, we observed a significant in-
crement in MMA levels accompanied by increments in
Hcy; the latter is better explained by age-related reduced
kidney function than by vitamin B12 insufficiency. Total
serum folate levels but not RBC folate levels decreased
with progressing age. The present work evaluated deci-
sion limits for the use of these parameters in the elderly.
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